- Home
- SPOK vs HQL Comparison
SPOK vs HQL Comparison
Compare SPOK & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPOK
- HQL
- Stock Information
- Founded
- SPOK 2004
- HQL 1992
- Country
- SPOK United States
- HQL United States
- Employees
- SPOK 406
- HQL N/A
- Industry
- SPOK Telecommunications Equipment
- HQL Investment Managers
- Sector
- SPOK Telecommunications
- HQL Finance
- Exchange
- SPOK Nasdaq
- HQL Nasdaq
- Market Cap
- SPOK 329.2M
- HQL 377.2M
- IPO Year
- SPOK 1992
- HQL N/A
- Fundamental
- Price
- SPOK $16.35
- HQL $13.40
- Analyst Decision
- SPOK Hold
- HQL
- Analyst Count
- SPOK 1
- HQL 0
- Target Price
- SPOK $15.00
- HQL N/A
- AVG Volume (30 Days)
- SPOK 88.6K
- HQL 120.9K
- Earning Date
- SPOK 10-30-2024
- HQL 01-01-0001
- Dividend Yield
- SPOK 7.70%
- HQL 11.56%
- EPS Growth
- SPOK N/A
- HQL N/A
- EPS
- SPOK 0.71
- HQL 0.79
- Revenue
- SPOK $137,714,000.00
- HQL N/A
- Revenue This Year
- SPOK $2.45
- HQL N/A
- Revenue Next Year
- SPOK $0.80
- HQL N/A
- P/E Ratio
- SPOK $22.91
- HQL $17.08
- Revenue Growth
- SPOK N/A
- HQL N/A
- 52 Week Low
- SPOK $13.24
- HQL $11.34
- 52 Week High
- SPOK $18.14
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- SPOK 59.68
- HQL 39.23
- Support Level
- SPOK $16.51
- HQL $13.76
- Resistance Level
- SPOK $16.86
- HQL $14.45
- Average True Range (ATR)
- SPOK 0.26
- HQL 0.15
- MACD
- SPOK -0.01
- HQL -0.01
- Stochastic Oscillator
- SPOK 77.93
- HQL 19.72
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.